A recent undercover investigation by pro-life organization Live Action has uncovered that Planned Parenthood is prescribing cross-sex hormones to minors, including 16-year-olds, with minimal medical oversight. The investigation involved posing as a 16-year-old seeking “gender-affirming care,” during which Planned Parenthood staff reportedly offered virtual consultations and suggested that parental presence was not required during in-person visits.
Live Action‘s findings indicate that Planned Parenthood is now the second-largest provider of cross-sex hormones in the United States. In 2023 alone, over 40,000 patients sought “gender-affirming care” from the organization, with approximately 40% aged between 18 and 22. These revelations have intensified calls from conservative leaders and organizations to reevaluate federal funding for Planned Parenthood, which currently receives around $700 million annually.
Critics argue that the ease with which minors can access potent, life-altering medications without comprehensive medical evaluations or parental involvement poses significant risks. They contend that such practices undermine parental rights and expose vulnerable youth to treatments with irreversible consequences. The investigation has sparked renewed debates over the ethical and medical standards of care provided by organizations like Planned Parenthood.
